Pages that link to "Q43299807"

The following pages link to Zdeněk Kleibl (Q43299807):

Displaying 50 items.

• High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area (Q24813558) (← links)
• Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data (Q31027996) (← links)
• Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemothera (Q33384675) (← links)
• Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis (Q35109800) (← links)
• Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic (Q35657899) (← links)
• Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma (Q35823280) (← links)
• Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer. (Q36098651) (← links)
• The role of ATM in breast cancer development. (Q36633080) (← links)
• Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint (Q36841814) (← links)
• Determining Omics spatiotemporal dimensions using exciting new nanoscopy techniques to assess complex cell responses to DNA damage: part A--radiomics. (Q38235010) (← links)
• The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells. (Q39412367) (← links)
• Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors. (Q40216087) (← links)
• Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic (Q40785671) (← links)
• Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients (Q43299749) (← links)
• Expression of attractin and its differential enzyme activity in glioma cells (Q43631663) (← links)
• Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene (Q43638942) (← links)
• The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer. (Q45352976) (← links)
• Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity (Q46087551) (← links)
• Expression of human BRCA1Δ17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage response. (Q46371993) (← links)
• Multiplex PCR and NGS-based identification of mRNA splicing variants: Analysis of BRCA1 splicing pattern as a model. (Q47789863) (← links)
• Population-based study of BRCA1/2 mutations: family history based criteria identify minority of mutation carriers (Q51574104) (← links)
• Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes. (Q52591829) (← links)
• The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. (Q52871118) (← links)
• Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women. (Q53174846) (← links)
• Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma. (Q54360211) (← links)
• Mutation analysis of the MYH gene in unrelated Czech APC mutation-negative polyposis patients. (Q54440826) (← links)
• Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case-control study. (Q54576290) (← links)
• CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer. (Q54661833) (← links)
• Mutations of the BRCA1 gene in hereditary breast and ovarian cancer in the Czech Republic. (Q54791713) (← links)
• Hereditary truncating mutations of DNA repair and other genes inBRCA1/BRCA2/PALB2-negatively tested breast cancer patients (Q59527193) (← links)
• Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations (Q60912514) (← links)
• Novel complex genomic rearrangement of the BRCA1 gene (Q61896418) (← links)
• Screening for inherited mutations in the Czech high risk breast cancer patients – analysis of 400 families (Q61896420) (← links)
• Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus (Q63438331) (← links)
• Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer (Q64039394) (← links)
• [PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic] (Q64389994) (← links)
• Rapid detection of CAA/CAG repeat polymorphism in the AIB1 gene using DHPLC (Q79595557) (← links)
• The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population (Q79815030) (← links)
• Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations (Q80144200) (← links)
• The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic (Q81601346) (← links)
• No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma (Q84045589) (← links)
• The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development (Q84116735) (← links)
• [CZECANCA: CZEch CAncer paNel for Clinical Application-- Design and Optimization of the Targeted Sequencing Panel for the Identification of Cancer Susceptibility in High-risk Individuals from the Czech Republic] (Q86952714) (← links)
• RE: frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk (Q88394472) (← links)
• Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon (Q90974923) (← links)
• A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants (Q91344892) (← links)
• Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer (Q91963289) (← links)
• Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system (Q92239198) (← links)
• CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate (Q104478232) (← links)
• (Q121976914) (← links)